NEXVET BIOPHARMA PUB LTD CO's ticker is NVET and the CUSIP is G6503X109. A total of 18 filers reported holding NEXVET BIOPHARMA PUB LTD CO in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $229,000 | +72.2% | 34,313 | 0.0% | 0.00% | – |
| Q1 2017 | $133,000 | +2.3% | 34,313 | -2.8% | 0.00% | – |
| Q4 2016 | $130,000 | -7.1% | 35,313 | 0.0% | 0.00% | – |
| Q3 2016 | $140,000 | -14.6% | 35,313 | 0.0% | 0.00% | – |
| Q2 2016 | $164,000 | +41.4% | 35,313 | 0.0% | 0.00% | – |
| Q1 2016 | $116,000 | -3.3% | 35,313 | 0.0% | 0.00% | – |
| Q4 2015 | $120,000 | -7.0% | 35,313 | 0.0% | 0.00% | – |
| Q3 2015 | $129,000 | -27.1% | 35,313 | -1.1% | 0.00% | – |
| Q2 2015 | $177,000 | -51.0% | 35,700 | -20.7% | 0.00% | – |
| Q1 2015 | $361,000 | – | 45,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 874,001 | $2,980,000 | 1.00% |
| Boxer Capital, LLC | 154,840 | $528,000 | 0.46% |
| Broadfin Capital, LLC | 721,595 | $2,461,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,503,696 | $8,538,000 | 0.08% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 875,000 | $2,984,000 | 0.01% |
| COWEN INC. | 27,485 | $94,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 44,400 | $151,000 | 0.00% |
| A.R.T. Advisors, LLC | 13,020 | $44,000 | 0.00% |
| NEXT Financial Group, Inc | 1,300 | $4,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 33,673 | $115,000 | 0.00% |